Skip to main content

Remote Job Finders (RJF)

Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially “hundreds of millions” in damages, John Kuckelman, the pharma’s general counsel, said. The wellness platform pulled its version of the drug just days after launching it.
Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill
Scroll to top